A pitvarfibrilláló betegek antikoaguláns kezelésének jelentosége a stroke megelozésében - A nemzetközi adatok és az újabb terápiás lehetoségek áttekintése

Translated title of the contribution: The importance of anticoagulant therapy in patients with artial fibrillation in stroke prevention - Summary of international data and novel therapeutic modalities

Ágnes Mirolovics, C. Papp, Judit Zsuga, D. Bereczki

Research output: Contribution to journalArticle

Abstract

The most common cardiogenic cause of ischaemic stroke is atrial fibrillation which increases the probability of stroke five-fold and doubles case fatality. Based on international data the incidence of atrial fibrillation is approx. 2% however this rapidly increases with age. The necessity of using oral anticoagulants in the prevention of non-valvular atrial fibrillation related stroke is decided based on estimated stroke risk. The CHADS2 and the more predictive CHA2DS2-VASc scales are used for this purpose while the bleeding risk of patients treated with anticoagulant may be estimated by the HAS-BLED scoring scale. For decades oral anticoagulation meant using vitamin-K antagonists. Based on international data we can see that rate of anticoagulation is unacceptably low, furthermore most of the anticoagulated patients aren't within the therapeutic range of INR (INR: 2-3). A lot of disadvantages of vitamin-K antagonists are known (e.g. food-drug interaction, need for regular coagulation monitoring, increased risk of bleeding), therefore compounds with new therapeutic target,have been developed. The novel oral anticoagulants (NOAC) can be divided in two major subgroups: direct thrombin inhibitors (dabigatran etexilate) and Xa-factor inhibitors (rivaroxaban, apixaban, edoxaban). These products are administered in fix doses, they less frequently interact with other medications or food, and regular coagulation monitoring is not needed when using these drugs. Moreover several studies have shown that they are at least as effective in the prevention of ischaemic stroke than the vitamin-K antagonists, with no more haemorrhagic complications.

Translated title of the contributionThe importance of anticoagulant therapy in patients with artial fibrillation in stroke prevention - Summary of international data and novel therapeutic modalities
Original languageHungarian
Pages (from-to)76-87
Number of pages12
JournalIdeggyógyászati szemle
Volume69
Issue number3-4
DOIs
Publication statusPublished - Mar 30 2016

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Medicine(all)

Fingerprint Dive into the research topics of 'The importance of anticoagulant therapy in patients with artial fibrillation in stroke prevention - Summary of international data and novel therapeutic modalities'. Together they form a unique fingerprint.

  • Cite this